Publications by authors named "Andrew D Ferguson"

Claim this Profile
N
Neoplastic and non-neoplastic lesions in biopsy samples from pet rabbits in Hong Kong: a retrospective analysis, 2019-2022.
Fraser I Hill, May P Y Tse, Andrew D Ferguson, Steve W Mills, Jeanine R Sandy

J Vet Diagn Invest· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel strain of lumpy skin disease virus causes clinical disease in cattle in Hong Kong.
John Flannery, Barbara Shih, Ismar R Haga, Martin Ashby, Amanda Corla, Andrew D Ferguson

Transbound Emerg Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Femoral Artery Closure Devices vs Manual Compression During Cardiac Catheterization and Percutaneous Coronary Intervention.
Rolf P Kreutz, Sujoy Phookan, Hamid Bahrami, Anjan K Sinha, Jeffrey A Breall, Andrew D Ferguson

J Soc Cardiovasc Angiogr Interv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Series of 7-Azaindoles as Potent and Highly Selective CDK9 Inhibitors for Transient Target Engagement.
Bernard Barlaam, Chris De Savi, Allan Dishington, Lisa Drew, Andrew D Ferguson, Douglas Ferguson

J Med Chem· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design of a new antibiotic class for drug-resistant infections.
Thomas F Durand-Reville, Alita A Miller, John P O'Donnell, Xiaoyun Wu, Mark A Sylvester, Andrew D Ferguson

Nature· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel, Potent Inhibitors of Hydroxy Acid Oxidase 1 (HAO1) Using DNA-Encoded Chemical Library Screening.
Esther C Y Lee, Andrew J McRiner, Katy E Georgiadis, Julie Liu, Zooey Wang, Andrew D Ferguson

J Med Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies.
Bernard Barlaam, Robert Casella, Justin Cidado, Calum Cook, Chris De Savi, Andrew D Ferguson, Douglas Ferguson

J Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of (2)--[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor.
Qibin Su, Erica Banks, Geraldine Bebernitz, Kirsten Bell, Cassandra F Borenstein, Andrew D Ferguson

J Med Chem· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the Substrate Specificity of the SMYD2 Protein Lysine Methyltransferase and Discovery of Novel Non-Histone Substrates.
Sara Weirich, Maren Kirstin Schuhmacher, Srikanth Kudithipudi, Cristiana Lungu, Andrew D Ferguson

Chembiochem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation of Glutamine Synthetase on Threonine 301 Contributes to Its Inactivation During Epilepsy.
Deborah Huyghe, Andrew R Denninger, Caroline M Voss, Pernille Frank, Ning Gao, Andrew D Ferguson

Front Mol Neurosci· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6.
William McCoull, Tony Cheung, Erica Anderson, Peter Barton, Jonathan Burgess, Andrew D Ferguson

ACS Chem Biol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase Inhibitors.
Neil P Grimster, Erica Anderson, Marat Alimzhanov, Geraldine Bebernitz, Kirsten Bell, Andrew D Ferguson

J Med Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 2,6-disubstituted pyrazine derivatives as inhibitors of CK2 and PIM kinases.
Lakshmaiah Gingipalli, Michael H Block, Larry Bao, Emma Cooke, Les A Dakin, Andrew D Ferguson

Bioorg Med Chem Lett· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Design of Selective Noncovalent CDK12 Inhibitors.
Jeffrey W Johannes, Christopher R Denz, Nancy Su, Allan Wu, Anna C Impastato, Andrew D Ferguson

ChemMedChem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88 Diffuse Large B-Cell Lymphoma.
James S Scott, Sébastien L Degorce, Rana Anjum, Janet Culshaw, Robert D M Davies, Andrew D Ferguson

J Med Chem· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors".
Jeffrey W Johannes, Stephanie Bates, Carl Beigie, Matthew A Belmonte, John Breen, Andrew D Ferguson

ACS Med Chem Lett· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors.
William McCoull, Roman D Abrams, Erica Anderson, Kevin Blades, Peter Barton, Andrew D Ferguson

J Med Chem· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors.
William McCoull, Roman D Abrams, Erica Anderson, Kevin Blades, Peter Barton, Andrew D Ferguson

J Med Chem· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors.
Jeffrey W Johannes, Stephanie Bates, Carl Beigie, Matthew A Belmonte, John Breen, Andrew D Ferguson

ACS Med Chem Lett· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of cofactor-specific, bactericidal Mycobacterium tuberculosis InhA inhibitors using DNA-encoded library technology.
Holly H Soutter, Paolo Centrella, Matthew A Clark, John W Cuozzo, Christoph E Dumelin, Andrew D Ferguson

Proc Natl Acad Sci U S A· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 Inhibitors.
William McCoull, Edward J Hennessy, Kevin Blades, Claudio Chuaqui, James E Dowling, Andrew D Ferguson

ACS Med Chem Lett· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Biological Activity of Substrate Competitive SMYD2 Inhibitors.
Scott D Cowen, Daniel Russell, Leslie A Dakin, Huawei Chen, Nicholas A Larsen, Andrew D Ferguson

J Med Chem· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitors.
Alexis I Cocozaki, Roger B Altman, Jian Huang, Ed T Buurman, Steven L Kazmirski, Andrew D Ferguson

Proc Natl Acad Sci U S A· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in Vivo.
James E Dowling, Marat Alimzhanov, Larry Bao, Claudio Chuaqui, Christopher R Denz, Andrew D Ferguson

ACS Med Chem Lett· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of azabenzimidazoles as potent JAK1 selective inhibitors.
Melissa M Vasbinder, Marat Alimzhanov, Martin Augustin, Geraldine Bebernitz, Kirsten Bell, Andrew D Ferguson

Bioorg Med Chem Lett· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis